# Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760)

> **NCT01159496** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-05212377 (SAM-760)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01159496
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159496, "Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01159496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*